Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by C. Even
Molecular profiling and access to treatment for rare cancers in Europe
Abstract Arcagen is a clinical study proposing a comprehensive analysis of molecular and clinical characteristics of rare adult solid cancers (11 domains: sarcomas, gynecology, uro-genital, GI, NET, head and neck, thoracic, skin and eyes, CNS and CUP) across Europe, utilizing the EORTC-SPECTA platform with the EURACAN ERN. This study enrolled 1235 advanced stage patients.
Learning through experimenting: an original way of teaching geometrical optics
Article Dans Une Revue European Journal of Physics Année : 2016 Learning through experimenting: an original way of teaching geometrical optics Origine : Fichiers éditeurs autorisés sur une archive ouverte hal-02022163 , version 1 (22-03-2024) C. Even, C. Balland, V. Guillet. Learning through experimenting: an original way of teaching geometrical optics. European Journal of Physics, 2016, 37 (6), pp.065707. ⟨10.1088/0143-0807/37/6/065707⟩.
Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study
Highlights • OS was not significantly different for durvalumab or for durvalumab plus tremelimumab compared with SoC. • The study was not designed to assess OS between immunotherapies, but adding tremelimumab did not appear to enhance durvalumab activity. • Failure to meet the primary end point may have been impacted by factors resulting in an unexpectedly long OS for the SoC arm.
Causes of death statistics underestimate the burden of head and neck (H&N) cancers: a nationwide study from France in 2008-2012 (EPICORL study)
Background: Patients with H&N cancer carry the highest risk of secondary primary cancers. Determining the underlying cause of death is conflicting in presence of multiple primary cancer sites, and the actual burden of H&N cancers may be underestimated by causes of death statistics.
High incidence of cetuximab-related infusion reactions in head and neck cancer pts (real life data)
High incidence of cetuximab-related infusion reactions in head and neck cancer pts (real life data) V. Palomar, M. Annereau, N. Lezghed, C. Even, L. Mayache-Badis, M. Iacob, C. Leibu, M. Matias, P. Bravo and C. Ferte Institut Gustave Roussy, Villejuif, France Background: Cetuximab is crucial in the management of squamous cell carcinoma of the head and neck (SCCHN) patients. Grade 3-4 infusion reactions (IRs) occur in 2% of colorectal cancer (ASPECCT study, ?1000 pts).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with C.
Contact C., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack